ICAM1 and atopic conjunctivitis: Based on their connectivity and since allergic rhinitis is frequently associated with comorbid allergic conjunctivitis (i.e., rhinoconjunctivitis) [212,213], it makes sense to also envision ICAM-1/allergen-specific nanobodies formulated as eye drops in the future (Figure 3).